8. INTANGIBLE ASSETS AND GOODWILL

Intangible assets and goodwill consists of the following:

 

 

 

 

 

December 31, 2025

 

 

December 31, 2024

 

(In thousands)

 

Weighted Amortizable Life (Years)

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Amount

 

 

Gross Carrying Amount

 

 

Accumulated Amortization

 

 

Net Carrying Amount

 

Goodwill

 

 

 

$

83,027

 

 

$

 

 

$

83,027

 

 

$

83,027

 

 

$

 

 

$

83,027

 

Finite-lived intangible assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Collaboration agreements

 

12

 

$

465,590

 

 

$

(465,590

)

 

$

 

 

$

465,590

 

 

$

(465,590

)

 

$

 

Capitalized IP

 

11-13

 

 

118,160

 

 

 

(117,345

)

 

 

815

 

 

 

118,160

 

 

 

(117,270

)

 

 

890

 

Total

 

 

 

$

583,750

 

 

$

(582,935

)

 

$

815

 

 

$

583,750

 

 

$

(582,860

)

 

$

890

 

The Company’s finite-lived intangible assets primarily consisted of collaborative agreements and the NANOCRYSTAL and oral controlled release technologies acquired as part of the EDT acquisition. These intangible assets were fully amortized in the year ended December 31, 2024. The Company recorded less than $0.1 million, $1.1 million and $35.7 million of amortization expense related to its finite-lived intangible assets during the years ended December 31, 2025, 2024 and 2023, respectively.

The Company performed its annual goodwill impairment test as of October 31, 2025. The Company elected to perform a qualitative impairment test and determined that based on the weight of all available evidence, the fair value of the reporting unit more-likely-than-not exceeded its carrying value.

Historical Timeline

Fiscal YearFiled
2025Feb 25, 2026Showing above
2024Feb 12, 2025
2023Feb 21, 2024
2022Feb 16, 2023
2021Feb 16, 2022
2020Feb 11, 2021
2019Feb 13, 2020
2018Feb 15, 2019
2017Feb 16, 2018
2016Feb 17, 2017
2015Feb 25, 2016

About Goodwill & Intangibles Disclosures

Goodwill and intangible asset disclosures reveal the premium paid in acquisitions and how management assesses whether that premium retains its value. Since goodwill is no longer amortized under US GAAP, the annual impairment test is the only mechanism that adjusts carrying values downward — making the assumptions behind that test critically important for investors.

Key signals: a history of goodwill impairments suggests management consistently overpays for acquisitions. Watch the gap between reporting unit fair value and carrying amount — when fair value exceeds carrying amount by less than 10-20%, a small decline in business performance could trigger a write-down. For finite-lived intangibles, examine useful life assumptions across customer relationships, technology, and trade names; aggressive estimates inflate near-term earnings. Compare total intangibles-to-total-assets ratios against peers to assess acquisition dependency. Rising goodwill as a percentage of equity can signal balance sheet fragility.